| 000 | 01183 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513043659.0 | ||
| 264 | 0 | _c19950724 | |
| 008 | 199507s 0 0 eng d | ||
| 022 | _a0025-7931 | ||
| 024 | 7 |
_a10.1159/000196491 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHodson, M E | |
| 245 | 0 | 0 |
_aClinical studies of rhDNase in moderately and severely affected patients with cystic fibrosis--an overview. _h[electronic resource] |
| 260 |
_bRespiration; international review of thoracic diseases _c1995 |
||
| 300 |
_a29-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCystic Fibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aDeoxyribonuclease I _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 |
_aExpectorants _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aRespiratory Tract Diseases _xdrug therapy |
| 773 | 0 |
_tRespiration; international review of thoracic diseases _gvol. 62 Suppl 1 _gp. 29-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000196491 _zAvailable from publisher's website |
| 999 |
_c7791795 _d7791795 |
||